Psychological Impact The rapid weight changes, increased focus on food and eating, and physical side effects can trigger anxiety, depression, and intensified eating disorder thoughts
[16] [17] Whether these risks apply to retatrutide specifically is not yet established, as the full long-term safety profile remains unknown pending Phase 3 data
Wound healing capacity in different tissues [1,2,1017] (including blood vessels) (i.e., stimulation of the early growth response 1 (egr-1) gene and its co-repressor nerve growth factor 1-A binding protein-2 (naB2) [17] also responsible for cytokine and growth factor generation and thereby, early extracellular matrix (collagen) and blood vessel formation [17]) and endothelium protection [1,2,14,15] were implicated in these counteracting effects
The medication remains in Phase 3 clinical trials, with FDA approval expected between late 2026 and early 2027
there are differences in bioavailability and regulatory concern
174,175 Additionally, in two separate double-blind clinical trials, 20 healthy individuals were given the antibiotic minocycline (Minocin) seven times over three days in order to induce vertigo, nystagmus, and nausea